Clinical and molecular epidemiology of community-onset invasive Staphylococcus aureus infection in New Zealand children

SUMMARY Our aim was to describe the epidemiology and incidence of community-onset invasive S. aureus disease in children presenting to our hospital, and to compare the clonal complexes and virulence genes of S. aureus strains causing invasive and non-invasive disease. The virulence gene repertoire of invasive disease isolates was characterized using DNA microarray and compared with the virulence gene repertoire of non-invasive S. aureus isolates. Over the study period, 163 children had an invasive S. aureus infection. There was no difference in the distribution of clonal complexes or in the prevalence of genes encoding virulence factors between invasive and non-invasive isolates. Future research should include a strong focus on identifying the host and environmental factors that, along with organism virulence factors, are contributing to the patterns of invasive S. aureus disease observed in New Zealand.

[1]  S. Monecke,et al.  Emergence and molecular characterization of clonal complex 398 (CC398) methicillin-resistant Staphylococcus aureus (MRSA) in New Zealand. , 2014, The Journal of antimicrobial chemotherapy.

[2]  M. D. Kraker,et al.  The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  J. Fraser,et al.  Clinical and Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in New Zealand: Rapid Emergence of Sequence Type 5 (ST5)-SCCmec-IV as the Dominant Community-Associated MRSA Clone , 2013, PloS one.

[4]  R. Goering,et al.  Subpopulations of Staphylococcus aureus Clonal Complex 121 Are Associated with Distinct Clinical Entities , 2013, PloS one.

[5]  M. Baker,et al.  Increasing Incidence and Sociodemographic Variation in Community-onset Staphylococcus Aureus Skin and Soft Tissue Infections in New Zealand Children , 2013, The Pediatric infectious disease journal.

[6]  Y. Maldonado,et al.  Staphylococcal Infections in Children, California, USA, 1985–2009 , 2013, Emerging infectious diseases.

[7]  Anne M Johnson,et al.  The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis , 2013, The Lancet. Infectious diseases.

[8]  S. Monecke,et al.  Rapid Microarray-Based Identification of Different mecA Alleles in Staphylococci , 2012, Antimicrobial Agents and Chemotherapy.

[9]  B. Cao,et al.  Characterization of Community Acquired Staphylococcus aureus Associated with Skin and Soft Tissue Infection in Beijing: High Prevalence of PVL+ ST398 , 2012, PloS one.

[10]  B. Sharma-Kuinkel,et al.  Panton-Valentine Leukocidin Is Not the Primary Determinant of Outcome for Staphylococcus aureus Skin Infections: Evaluation from the CANVAS Studies , 2012, PloS one.

[11]  Chih-Chien Wang,et al.  Panton-Valentine leukocidin in the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. , 2011, Pediatrics and neonatology.

[12]  P. Boisier,et al.  Epidemiology of methicillin-susceptible Staphylococcus aureus lineages in five major African towns: high prevalence of Panton-Valentine leukocidin genes. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  M. Baker,et al.  Increasing hospitalizations for serious skin infections in New Zealand children, 1990–2007 , 2010, Epidemiology and Infection.

[14]  G. Pier,et al.  High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  M. McDonald,et al.  Clinical correlates of Panton-Valentine leukocidin (PVL), PVL isoforms, and clonal complex in the Staphylococcus aureus population of Northern Australia. , 2010, The Journal of infectious diseases.

[16]  P. Reed,et al.  Incidence, Risk Factors, and Outcomes of Panton-Valentine Leukocidin-Positive Methicillin-Susceptible Staphylococcus aureus Infections in Auckland, New Zealand , 2010, Journal of Clinical Microbiology.

[17]  R. Daum,et al.  Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic , 2010, Clinical Microbiology Reviews.

[18]  Rogan Lee,et al.  Clinical and laboratory features of invasive community-onset methicillin-resistant Staphylococcus aureus infection: a prospective case–control study , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[19]  A. Harris,et al.  Predictive Ability of Positive Clinical Culture Results and International Classification of Diseases, Ninth Revision, to Identify and Classify Noninvasive Staphylococcus aureus Infections: A Validation Study , 2010, Infection Control & Hospital Epidemiology.

[20]  Jon R. Armstrong,et al.  contribution of genetically restricted, methicillin-susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  F. Vandenesch,et al.  Serum antibodies against Panton-Valentine leukocidin in a normal population and during Staphylococcus aureus infection. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[22]  S. Monecke,et al.  Assignment of Staphylococcus aureus isolates to clonal complexes based on microarray analysis and pattern recognition. , 2008, FEMS immunology and medical microbiology.

[23]  H. Boucher,et al.  Epidemiology of methicillin-resistant Staphylococcus aureus. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  F. Lowy,et al.  Pathogenesis of methicillin-resistant Staphylococcus aureus infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  P. Giffard,et al.  Methicillin-susceptible, non-multiresistant methicillin-resistant and multiresistant methicillin-resistant Staphylococcus aureus infections: a clinical, epidemiological and microbiological comparative study , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[26]  Roberta B Carey,et al.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States. , 2007, JAMA.

[27]  C. Nelson,et al.  Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. , 2007, The Journal of infectious diseases.

[28]  Roberta B Carey,et al.  Methicillin-resistant S. aureus infections among patients in the emergency department. , 2006, The New England journal of medicine.

[29]  S. Monecke,et al.  Microarray-based characterisation of a Panton-Valentine leukocidin-positive community-acquired strain of methicillin-resistant Staphylococcus aureus. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[30]  P. Vanhems,et al.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients , 2002, The Lancet.

[31]  P. Hill,et al.  Prospective study of 125 cases of Staphylococcus aureus bacteremia in children in New Zealand. , 2001, The Pediatric infectious disease journal.

[32]  M. Birch,et al.  Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality , 2001, Internal medicine journal.

[33]  Marti J. Anderson,et al.  A new method for non-parametric multivariate analysis of variance in ecology , 2001 .

[34]  Brian H. McArdle,et al.  FITTING MULTIVARIATE MODELS TO COMMUNITY DATA: A COMMENT ON DISTANCE‐BASED REDUNDANCY ANALYSIS , 2001 .

[35]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .

[36]  M. Monnet.  [Staphylococcal infections in children]. , 1967, Lyon medical.